Yes, a Japan DMAH (Designated Marketing Authorization Holder) can handle biologics and advanced therapy products. They ensure compliance with Japanese regulations, manage product registration, and oversee post-marketing surveillance. Collaborating with local experts, they facilitate market entry and maintain product quality, safety, and efficacy in alignment with Japan’s stringent standards.
